home / stock / cstl / cstl news

CSTL News and Press, Castle Biosciences Inc. From 06/19/25

Stock Information
Company Name: Castle Biosciences Inc.
Stock Symbol: CSTL
Market: NASDAQ
Website: castlebiosciences.com
Menu
CSTL CSTL Quote CSTL Short CSTL News CSTL Articles CSTL Message Board
Get CSTL Alerts

News, Short Squeeze, Breakout and More Instantly...
CSTL - Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FRIENDSWOOD, Texas, June 19, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2025, the Compensation Committee of its Board of Directors granted restricted stock units (R...
CSTL - Castle Biosciences partners with SciBase for diagnostic tests

2025-06-16 17:11:08 ET More on Castle Biosciences Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call Transcript Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern Castle Biosciences projects $287-$297M revenue for 2025 amid strate...

CSTL - Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases

FRIENDSWOOD, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has entered into a collaboration and license agreement with SciBase Holding AB (“SciBase&...

CSTL - Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention

FRIENDSWOOD, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, founder, president and chief executive officer of Castle Biosciences, will particip...
CSTL - Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards®

Gold-level Stevie® Award recognizes Maetzold’s transformative leadership in the healthcare industry, including molecular diagnostics and precision medicine FRIENDSWOOD, Texas, June 04, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improvi...

CSTL - New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes

FRIENDSWOOD, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present novel research aimed at enhancing the clinical management of patients with cutaneous melanoma (CM) and uveal mela...

CSTL - Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference

FRIENDSWOOD, Texas, May 21, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the 2025 Jefferies Global Hea...
CSTL - Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result

FRIENDSWOOD, Texas, May 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from the first independent validation of the recently published Collaborative Ocular Oncology Group S...

CSTL - Castle Biosciences projects $287-$297M revenue for 2025 amid strategic acquisitions and growth initiatives

2025-05-06 13:39:30 ET More on Castle Biosciences Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call Transcript Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript ...

CSTL - Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call Transcript

2025-05-05 22:58:07 ET Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Conference Call May 5, 2025 16:30 ET Company Participants Camilla Zuckero - Vice President of Investor Relations and Corporate Affairs Derek Maetzold - Founder, President & Chief Executive Of...
Previous 10 Next 10